Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 88,157 | N/A | N/A |
| Receivables | N/A | N/A | 836 | N/A | N/A |
| Other current assets | 113,858 | 0 | 0 | 0 | 0 |
| TOTAL | $113,858 | $96,468 | $89,940 | $56,135 | $59,137 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 490 | N/A | N/A |
| Other Non-Current Assets | 4,572 | 4,679 | 4,212 | 1,463 | 1,558 |
| TOTAL | $4,572 | $4,679 | $4,702 | $1,463 | $1,558 |
| Total Assets | $118,430 | $101,147 | $94,642 | $57,598 | $60,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | N/A | N/A | 3,325 | N/A | N/A |
| TOTAL | $N/A | $N/A | $3,633 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 578 | 0 | 0 |
| TOTAL | $N/A | $N/A | $578 | $N/A | $N/A |
| Total Liabilities | $3,837 | $4,677 | $4,211 | $4,804 | $4,978 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 3 | N/A | N/A |
| Retained earnings | N/A | N/A | -71,503 | N/A | N/A |
| Other shareholders' equity | 114,593 | 96,470 | -374 | 52,794 | 55,717 |
| TOTAL | $114,593 | $96,470 | $90,431 | $52,794 | $55,717 |
| Total Liabilities And Equity | $118,430 | $101,147 | $94,642 | $57,598 | $60,695 |